1. Home
  2. RNP vs CDNA Comparison

RNP vs CDNA Comparison

Compare RNP & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers REIT and Preferred and Income Fund Inc.

RNP

Cohen & Steers REIT and Preferred and Income Fund Inc.

HOLD

Current Price

$21.06

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$22.77

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RNP
CDNA
Founded
2003
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
RNP
CDNA
Price
$21.06
$22.77
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$28.00
AVG Volume (30 Days)
76.1K
583.8K
Earning Date
01-01-0001
04-28-2026
Dividend Yield
7.94%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
$48,324,000.00
Revenue This Year
N/A
$16.01
Revenue Next Year
N/A
$11.31
P/E Ratio
N/A
$455.40
Revenue Growth
N/A
18.93
52 Week Low
$19.27
$10.96
52 Week High
$22.99
$23.24

Technical Indicators

Market Signals
Indicator
RNP
CDNA
Relative Strength Index (RSI) 57.12 65.92
Support Level $20.44 $15.80
Resistance Level $21.24 $22.89
Average True Range (ATR) 0.28 0.95
MACD 0.01 0.11
Stochastic Oscillator 62.10 90.52

Price Performance

Historical Comparison
RNP
CDNA

About RNP Cohen & Steers REIT and Preferred and Income Fund Inc.

Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances. The Fund seeks to achieve its objectives through a portfolio of income producing common stock issued by REITs and preferred and other debt securities.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: